Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
284.3 USD | -0.69% | +2.66% | -1.28% |
Mar. 09 | Amgen Presents New Research on Otezla at AAD 2024 | CI |
Mar. 06 | Amgen Keeps Q2 Dividend at $2.25 a Share, Payable June 7 to Stockholders of Record May 17 | MT |
Financials (USD)
Sales 2024 * | 33.01B | Sales 2025 * | 34.06B | Capitalization | 152B |
---|---|---|---|---|---|
Net income 2024 * | 6.13B | Net income 2025 * | 7.57B | EV / Sales 2024 * | 6.03 x |
Net Debt 2024 * | 46.57B | Net Debt 2025 * | 40.77B | EV / Sales 2025 * | 5.67 x |
P/E ratio 2024 * |
24.6
x | P/E ratio 2025 * |
19.1
x | Employees | 26,700 |
Yield 2024 * |
3.25% | Yield 2025 * |
3.52% | Free-Float | 99.75% |
Latest transcript on Amgen Inc.
1 day | -0.69% | ||
1 week | +2.66% | ||
Current month | +3.83% | ||
1 month | +2.47% | ||
3 months | -1.44% | ||
6 months | +4.98% | ||
Current year | -1.28% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 61 | 06-05-31 |
Peter Griffith
DFI | Director of Finance/CFO | 65 | 19-10-22 |
Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Holley
BRD | Director/Board Member | 67 | 17-02-02 |
Ellen Kullman
BRD | Director/Board Member | 68 | 16-10-13 |
Robert Williams
BRD | Director/Board Member | 75 | 14-10-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.84% | 0 M€ | 0.00% | - | |
7.63% | 0 M€ | 0.00% | - | |
5.08% | 108 M€ | +13.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 284.3 | -0.69% | 2,289,919 |
24-03-27 | 286.3 | +1.61% | 2,256,315 |
24-03-26 | 281.8 | +0.34% | 3,343,181 |
24-03-25 | 280.8 | +1.68% | 2,954,416 |
24-03-22 | 276.2 | -0.28% | 2,303,249 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.28% | 152B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |